SMTL ID : 3she.1

Novel ATP-competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.25 Å

Oligo State

monomer

Ligands

1 x I85: N-{4-[(3S)-4'-oxo-1',4',5',6'-tetrahydrospiro[piperidine-3,7'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-3-(trifluoromethyl)benzamide(Non-covalent)

I85.1: 19 residues within 4Å: Chain A: L.18, G.19, L.20, G.21, V.26, A.39, K.41, M.86, E.87, C.88, M.89, E.90, G.91, G.92, E.138, N.139, L.141, K.145, D.155 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.18, A:V.26, A:A.39, A:E.90, A:L.141 Hydrogen bonds: A:M.89, A:E.138, A:D.155 Water bridges: A:D.155

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Oubrie, A. et al., Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series. Bioorg.Med.Chem.Lett. (2012)

Release Date

2011-12-14

Peptides

MAP kinase-activated protein kinase 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MAP kinase-activated protein kinase 3

Related Entries With Identical Sequence